Welcome
Support Centre
04 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
NESTAC: North of England Study of Tonsillectomy and Adeno-tonsillectomy in Children
ISRCTN ISRCTN47891548
ClinicalTrials.gov identifier
Public title NESTAC: North of England Study of Tonsillectomy and Adeno-tonsillectomy in Children
Scientific title
Acronym NESTAC
Serial number at source HTA 99/20/03
Study hypothesis 1. To investigate the clinical effectiveness of surgical intervention compared with non-surgical intervention in children under 16 with recurrent sore throat.
2. To investigate the relative costs and benefits of surgical and non-surgical interventions to the NHS and families.
3. To identify important outcomes for children and parents and to evaluate the impact on children's quality of life.
4. To investigate older children's and parents' preference for different treatment options.

Protocol can be found at http://www.hta.ac.uk/protocols/199900200003.pdf
More details can be found at http://www.hta.ac.uk/1212
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Ear, nose and throat diseases
Participants - inclusion criteria Children <16 years with recurrent sore throat
Participants - exclusion criteria Added 21/06/10:
1. Hospitalisation due to peritonsillar abscess (quinsy)
2. Obstructive symptoms suggestive of clinicially significant sleep apnoea syndrome
3. Rare medical conditions such as glomerulonephritis or Henoch Schonlein purpura
4. Previous tonsillectomy
5. Suspected velopharyngeal insufficiency
6. Co-morbidity that means patient is unable to undergo surgery within the next six months
7. Bleeding disorders
8. Congenital/valvular heart disease
Anticipated start date 01/09/2001
Anticipated end date 31/08/2008
Status of trial Completed
Patient information material
Target number of participants 406
Interventions Please note that, as of 15 January 2008, the anticipated end date of this trial has been updated from 30 September 2006 to 31 August 2008.

Interventions:
Surgical intervention vs non-surgical intervention
Primary outcome measure(s) The number of reported episodes of sore throat in the two years following date of randomisation.
Secondary outcome measure(s) 1. The number of recorded episodes of sore throat from primary care practice records
2. Surgical and anaesthetic morbidity
3. Time off school
4. Parental time off work
5. Consumption of antibiotics and analgesics
6. Health-related quality of life
7. Child and parental satisfaction
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications 1. 2006 protocol in http://www.ncbi.nlm.nih.gov/pubmed/16899123
2. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20302811
Contact name Prof  John  Bond
  Address Centre for Health Services Research
University of Newcastle upon Tyne
21 Claremont Place
  City/town Newcastle upon Tyne
  Zip/Postcode NE2 4AA
  Country United Kingdom
  Tel +44 (0)191 222 6777
  Fax +44 (0)191 222 6043
  Email john.bond@newcastle.ac.uk
Sponsor Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
  Address Freeman Hospital
Freeman Road
High Heaton
  City/town Newcastle upon Tyne
  Zip/Postcode NE7 7DN
  Country United Kingdom
  Tel +44 (0)191 233 6161
  Email
  Sponsor website: http://www.newcastle-hospitals.org.uk/index.aspx
Date applied 25/04/2003
Last edited 21/06/2010
Date ISRCTN assigned 25/04/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central